Studying the C174g Polymorphism of The Il6 Gene in the Formation of Diabetic Foot Syndrome in Patients with Diabetes Mellitus
DOI:
https://doi.org/10.62480/tjms.2023.vol25.pp24-27Keywords:
Diabetic Foot, Gene Polymorphism, Diabetes MellitusAbstract
The criteria for risk stratification of the formation of diabetic foot syndrome in patients with diabetes mellitus based on the carriage of the interleukin 6 gene were studied. The clinical group included 96 patients aged 40 to 75 years with diabetes mellitus complicated by diabetic foot syndrome. The control group consisted of 83 healthy individuals. The results obtained by the authors demonstrate that the presence of the C/G genotype of the C174G polymorphism of the IL6 gene has a clear correlation with predisposition to the development of diabetic foot syndrome. In order to effectively prevent the development of diabetic foot syndrome, it is advisable to recommend genotyping of the C174G polymorphism in the IL6 gene
References
Akbari M. and Hassan-Zadeh V. (2018) IL-6 signalling pathways and the development of type 2 diabetes. Inflammopharmacology 26, 685–698 10.1007/s10787-018-0458-0
Chang W.T., Huang M.C., Chung H.F. et al.. (2016) Interleukin-6 gene polymorphisms correlate with the progression of nephropathy in Chinese patients with type 2 diabetes: A prospective cohort study. Diabetes Res. Clin. Pract. 120, 15–23 10.1016/j.diabres.2016.07.013
Chen B., Wu M., Zang C. et al.. (2019) Association Between IL-6 Polymorphisms and Diabetic Nephropathy Risk: A Meta-analysis. Am. J. Med. Sci. 358, 363–373 10.1016/j.amjms.2019.07.011
Dadabaev O.T., Aleinik V.A., Musashaihov H.T., Vasilevskiy E.A. Prognostic significance of VEGFA and IL6 gene polymorphism in diabetic foot syndrome //JournalNX- A Multidisciplinary Peer Reviewed Journal. – 2022.
– №11(8). – P. 279-285.
Dhamodharan U., Viswanathan V., Krishnamoorthy E. et al.. (2015) Genetic association of IL-6, TNF-alpha and SDF-1 polymorphisms with serum cytokine levels in diabetic foot ulcer. Gene 565, 62–67 10.1016/j.gene.2015.03.063
Ellingsgaard H., Hauselmann I., Schuler B. et al.. (2011) Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat. Med. 17, 1481–1489 10.1038/nm.2513
Guariguata L., Whiting D.R., Hambleton I. et al. (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res. Clin. Pract. 103, 137–149 10.1016/j.diabres.2013.11.002
Henning R.J. (2018) Type-2 diabetes mellitus and cardiovascular disease. Fut. Cardiol. 14, 491–509 10.2217/fca-2018-0045
Hui P., Jia S., Ma W. et al.. (2015) The changes and significance of IL-6 levels in patients with OSAHS associated Type 2 diabetes Mellites. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 29, 1726–1728
Ishihara K. and Hirano T. (2002) IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 13, 357–368 10.1016
Mathers C.D. and Loncar D. (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3, e442 10.1371/journal.pmed.0030442
Mysliwska J., Zorena K., Mysliwiec M. et al.. (2009) The -174GG interleukin-6 genotype is protective from retinopathy and nephropathy in juvenile onset type 1 diabetes mellitus. Pediatr. Res. 66, 341–345 10.1203/PDR.0b013e3181b1bd05
Nadeem A., Mumtaz S., Naveed A.K. et al.. (2017) Association of IL-6 C-174G (rs 1800795) single nucleotide polymorphism with type 2 diabetes mellitus in Pakistani population. J. Pak. Med. Assoc. 67, 428–433
Paine S.K., Sen A., Choudhuri S. et al.. (2012) Association of tumor necrosis factor alpha, interleukin 6, and interleukin 10 promoter polymorphism with proliferative diabetic retinopathy in type 2 diabetic subjects. Retina 32, 1197–1203 10.1097/IAE.0b013e31822f55f3
Ururahy M.A., de Souza K.S., Oliveira Y.M. et al.. (2015) Association of polymorphisms in IL6 gene promoter region with type 1 diabetes and increased albumin-to-creatinine ratio. Diabetes Metab. Res. Rev. 31, 500–506 10.1002/dmrr.2621
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
